Lisa A. Prosser
Economics, Econometrics and Finance · University of Michigan
Publications
236
Citations
13,400
Est. group size
~19
Recurring co-author estimate
Active years
27
Publishing since 2000
Typically publishes in teams of ~6 · 38% small-team papers (≤3 authors) · across 17 venues
- Cost-Effectiveness of Universal Newborn Screening and Disease-Modifying Therapies for Spinal Muscular Atrophy in Taiwan
Value in Health Regional Issues · 2026
- Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force
Value in Health · 2026
- PP07 Vaccine Decision-making In Canada: Processes And Guidelines For Using Economic Evidence
International Journal of Technology Assessment in Health Care · 2023
- EE211 Guidelines for the Economic Evaluation of Vaccination Programs in Canada
Value in Health · 2023
- Guidelines for the Economic Evaluation of Vaccination Programs in Canada
SSRN Electronic Journal · 2023
- Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force
PharmacoEconomics · 2023
- Developing Criteria for Health Economic Quality Evaluation Tool
Value in Health · 2023
- Families’ healthcare experiences for children with inherited metabolic diseases: protocol for a mixed methods cohort study
BMJ Open · 2022
- Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years
Value in Health · 2022
- Innovations in cost-effectiveness analysis that advance equity can expand its use in health policy
BMJ Global Health · 2022
- Incorporating Cascade Effects of Genetic Testing in Economic Evaluation: A Scoping Review of Methodological Challenges
Children · 2021
- Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review
Value in Health · 2020
- Call for transparency of COVID-19 models
Science · 2020
- Avoiding Harm From Hyperbilirubinemia Screening—Reply
JAMA Pediatrics · 2019
- Screening for Neonatal Hyperbilirubinemia—First Do No Harm?
JAMA Pediatrics · 2019
- Diabetes Care×18
- Value in Health×11
- Vaccine×8
- JAMA Pediatrics×7
- PEDIATRICS×6
- Jeff Richardson
Economics, Econometrics and Finance · Purdue University West Lafayette
- John F. P. Bridges
Economics, Econometrics and Finance · The Ohio State University
- A. Mark Fendrick
Economics, Econometrics and Finance · University of Michigan
- AM Fendrick
Economics, Econometrics and Finance · University of Michigan
- Andrew Stevens
Economics, Econometrics and Finance · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile